CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Athersys
Athersys logo

Athersys

Athersys, Inc.: A US-based biotech firm developing allogeneic stem cell products for various health conditions.

Cleveland, OH, US🇺🇸
Founded
1995
Overview
Compare
Fundraising
Employees

Athersys, Inc. is a biotechnology company based in Cleveland, United States, focused on developing allogeneic stem cell products. Their mission is to treat inflammatory and immune disorders, neurological conditions, cardiovascular disease, and other health conditions. Athersys serves patients globally, aiming to improve health outcomes through innovative stem cell therapies.

Athersys has made significant strides in the biotech industry, contributing to advancements in stem cell research and therapy. Their products have the potential to address unmet medical needs and improve patient care. The company's impact is reflected in its growing presence in the global healthcare market.

Athersys - Similar Companies

AlphaStem logo

AlphaStem

alpha-stim.com

Stemcyte logo

Stemcyte

stemcyte.com

U.S. Stem Cell logo

U.S. Stem Cell

us-stemcell.com

Platelet BioGenesis logo

Platelet BioGenesis

Celularity logo

Celularity

celularity.com

International Stem Cell logo

International Stem Cell

Celltex Therapeutics logo

Celltex Therapeutics

celltexbank.com

StemBioSys logo

StemBioSys

stembiosys.com

Vericel logo

Vericel

vcel.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Century Therapeutics logo

Century Therapeutics

centurytx.com

ImStem Biotechnology logo

ImStem Biotechnology

imstem.com

Stemtech logo

Stemtech

stemtech.com

Ossium Health logo

Ossium Health

ossiumhealth.com

Altos Labs logo

Altos Labs

altoslabs.com

Athersys - Quick Facts

Who are Athersys' competitors?

Companies similar to Athersys include AlphaStem, Stemcyte, U.S. Stem Cell and Platelet BioGenesis.

When was Athersys founded?

Athersys was founded in 1995.

Where is Athersys' headquarters located?

Athersys' headquarters is located in Cleveland, OH, US.

When was Athersys' last funding round?

Athersys' most recent funding round was for $3.7M (USD) in April 2023.

How much disclosed funding has Athersys raised?

As of Apr 18, 2023, Athersys has disclosed funding of $208.9M (USD). Undisclosed round amounts are excluded.

How many employees does Athersys have?

Athersys has 83 employees as of Feb 6, 2024.

Athersys - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Stem Cell Products
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 9900Nonclassifiable Establishments
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research